HIA
DGX icon

HFM Investment Advisors’s Quest Diagnostics DGX Stock Holding History

HFM Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76K Buy
13
+7
+117% +$1.37K ﹤0.01% 337
2026
Q1 		$1.18K Hold
6
– – ﹤0.01% 353
2025
Q4 		$1.04K Hold
6
– – ﹤0.01% 439
2025
Q3 		$1.14K Sell
6
-1
-14% -$177 ﹤0.01% 317
2025
Q2 		$1.26K Buy
7
+4
+133% +$695 ﹤0.01% 288
2025
Q1 		$508 Buy
+3
New +$493 ﹤0.01% 281

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HFM Investment Advisors's DGX Position: Q2 2026 in Review

HFM Investment Advisors increased its Quest Diagnostics (DGX) stake by 117% in Q2 2026, buying an estimated $1.37K and bringing the position to 13 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

HFM Investment Advisors first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • HFM Investment Advisors held 13 shares of Quest Diagnostics worth $2.76K as of Q2 2026.
  • HFM Investment Advisors bought 7 Quest Diagnostics shares in Q2 2026, an estimated $1.37K.
  • Quest Diagnostics made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #337 holding.
  • HFM Investment Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.